Variation in uptake and dose reduction of CDK4/6 inhibitors for the treatment of breast cancer in England, 2019-2024: a descriptive observational study using OpenPrescribing Hospitals
Fisher L., Polwart C., Wood C., Goldacre B., Anderson L., Isherwood J., Hindocha S., MacKenna B., Speed V.